Lobbying client
AURINIA PHARMACEUTICALS
biotech development and commercialization
Filings
7
Filed by
1
Reported in-house
—
Reported by firms
$120,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2017 to 2019
Filings
2 filings for 2017, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Report (No Activity) 4th Quarter 2017
|
THE ROSS GROUP, LLC | $7,500 reported |
|
Registration 4th Quarter 2017
|
THE ROSS GROUP, LLC | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE ROSS GROUP, LLC | 6 | $120,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 6 |
| Medicare/Medicaid | MMM | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.